Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 30 (2011), Issue 5, Pages 221-227
http://dx.doi.org/10.3233/DMA-2011-0777

α-Defensin 1-3 And α-Defensin 4 as Predictive Markers of Imatinib Resistance and Relapse in CML Patients

Gabriel Etienne,1,2 Maryse Dupouy,1 Patricia Costaglioli,3 Claudine Chollet,4 Valérie Lagarde,1 Jean-Max Pasquet,1 Josy Reiffers,2 Bertrand Garbay,3 François-Xavier Mahon,1,4 and Béatrice Turcq1

1Laboratoire Hématopoïèse Leucémique et Cibles Thérapeutiques, INSERM U876, Université Victor Segalen Bordeaux 2, Bordeaux, France
2Institut Bergonié, Centre Régional de Lutte Contre le Cancer de Bordeaux et du Sud-Ouest, Bordeaux, France
3Université de Bordeaux, IPB, EA 4135, ENSTBB, Bordeaux, France
4Laboratoire Hématologie, Hôpital Haut-Lévêque, CHU de Bordeaux, Bordeaux, France

Received 28 June 2011; Accepted 28 June 2011

Copyright © 2011 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Gabriel Etienne, Maryse Dupouy, Patricia Costaglioli, et al., “α-Defensin 1-3 And α-Defensin 4 as Predictive Markers of Imatinib Resistance and Relapse in CML Patients,” Disease Markers, vol. 30, no. 5, pp. 221-227, 2011. doi:10.3233/DMA-2011-0777